CDH2 and breast cancer: On the other hand, in breast cancer cells, therewas no change in the mRNA levels of EMT markers other than a decreasein N-cadherin in MCF7, which was not anticipatedconsidering the shift toward a more migratory and invasive phenotypein response to SEMA6D overexpression.